Progressive augmentation and ventilatory long-term facilitation are enhanced in sleep apnoea patients and are mitigated by antioxidant administration.
about
Drug therapy for obstructive sleep apnoea in adultsIntermittent hypoxia: a low-risk research tool with therapeutic value in humansDifferential expression of respiratory long-term facilitation among inbred rat strains.Treatment of Obstructive Sleep Apnea. Prospects for Personalized Combined Modality Therapy.Preinspiratory and inspiratory hypoglossal motor output during hypoxia-induced plasticity in the rat.Ventilatory long-term facilitation in humans.Phrenicotomy alters phrenic long-term facilitation following intermittent hypoxia in anesthetized ratsThe hypoxic ventilatory response and ventilatory long-term facilitation are altered by time of day and repeated daily exposure to intermittent hypoxiaExperimental protocols and preparations to study respiratory long term facilitationTherapeutic potential of intermittent hypoxia: a matter of dose.Obstructive sleep apnea and type 2 diabetesImpact of repeated daily exposure to intermittent hypoxia and mild sustained hypercapnia on apnea severityVentilatory responses after major surgery and high dependency care.Intermittent hypoxia and neurorehabilitation.The impact of arousal state, sex, and sleep apnea on the magnitude of progressive augmentation and ventilatory long-term facilitation.Power spectral analysis of hypoglossal nerve activity during intermittent hypoxia-induced long-term facilitation in mice.Sleep-disordered breathing and oxidative stress in preclinical chronic mountain sickness (excessive erythrocytosis)Chapter 3--networks within networks: the neuronal control of breathing.Ventilatory long-term facilitation is evident after initial and repeated exposure to intermittent hypoxia in mice genetically depleted of brain serotoninTime Domains of the Hypoxic Ventilatory Response and Their Molecular Basis.Intermittent hypoxia, respiratory plasticity and sleep apnea in humans: present knowledge and future investigations.Long-term facilitation of ventilation in humans with chronic spinal cord injuryAcute intermittent hypoxia induced neural plasticity in respiratory motor control.Signalling mechanisms of long term facilitation of breathing with intermittent hypoxia.Long-term facilitation of ventilation following acute continuous hypoxia in awake humans during sustained hypercapnia.Exposure to intermittent hypoxia and sustained hypercapnia reduces therapeutic CPAP in participants with obstructive sleep apnea.Intermittent hypercapnic hypoxia during sleep does not induce ventilatory long-term facilitation in healthy males.Enhancement of phrenic long-term facilitation following repetitive acute intermittent hypoxia is blocked by the glycolytic inhibitor 2-deoxyglucose.Short-term modulation of the ventilatory response to exercise is preserved in obstructive sleep apnea.Early life exposure to chronic intermittent hypoxia causes upper airway dilator muscle weakness, which persists into young adulthood.Electrophysiological properties of laryngeal motoneurones in rats submitted to chronic intermittent hypoxia.Intermittent hypercapnia-induced phrenic long-term depression is revealed after serotonin receptor blockade with methysergide in anaesthetized rats.Tempol ameliorates pharyngeal dilator muscle dysfunction in a rodent model of chronic intermittent hypoxia.Respiratory plasticity in sleep apnoea: should it be harnessed or restrained?Inherent vs. Induced Loop Gain Abnormalities in Obstructive Sleep Apnea
P2860
Q24202857-AEB893BA-DE72-4466-B27E-18E4A434CA99Q26824915-160AE1DE-C663-4A63-8ED1-12F9D16C90C3Q33749220-FE23B345-699A-4B49-AD84-FC49553487B1Q33772394-37D8B1E1-ABD6-4AC6-8C33-FC93C7B07752Q33841137-D5D15CCB-3E5B-4725-92C4-D3A274126C36Q33901665-259CE8F3-85C5-40F0-B915-B874A7A241E6Q34085511-88F734BF-E341-46F5-B7E0-E9C16C0709DEQ34132243-88358DF7-7CAC-43ED-9412-8D0B4B6DC3ACQ34663312-525E9005-BC54-40B8-A944-D546FCAF99CDQ35043452-BD188DFF-996B-4F8D-9568-D6D241B803F3Q35179113-DF5B5FC7-91EF-4D1B-8728-676AF3D44141Q35787447-9DCD8B58-B1B0-4EB9-A66D-30F2ED0F6F5EQ35885331-292F821B-FBBE-4A01-B64B-7617AC813C11Q36382232-04DAC578-52E3-4719-A940-3E36734AB248Q36531006-293F8CB1-4E30-487D-8F50-908C13407215Q36729720-7079C4A5-5E89-497C-B29F-54253BAC2CB7Q36736012-D4A4F235-D8BB-4A8E-8902-FE01ACC0DFD5Q36838975-99CD9973-5E2F-4926-BBB8-1C6EFF8151E0Q36942242-42EC0500-9E12-43F0-906E-1C1587B2C9CDQ37069679-BD3E6BD9-E6C4-4FFA-925D-3B93FE61C4F5Q37179232-B669988E-ACC7-4523-AB66-F71178272632Q37572499-057088B1-4D84-460F-AED8-A8F19F95A84FQ38115569-E727CAF6-BF33-41C4-A859-321969228092Q42144708-6865727E-E3D1-4C8B-9B6B-10ED1D3454F3Q46145758-0D1AC87F-D2EA-4A93-96E8-707BF4D70BD3Q46442994-47B82633-9E89-4A71-A3CF-E25F023FA4B3Q47719982-56031D87-07AB-4D94-B84E-8C8AB89AA181Q47747292-1C633D38-4264-467A-AF25-5944423B3D8CQ47794321-BB0EAA6B-F80B-423D-9DC6-C9055CA9D214Q47962838-69AC973F-1F1D-4FB4-9A04-01E468F9C905Q48014004-44F715D4-492D-4B5F-A0EC-373F0CD80A4FQ48069484-B80955E4-8354-4498-AC91-13BF1000B3F3Q48286525-5808D598-6003-4EF8-BA3A-82C682142451Q48376142-771DED54-CDE8-43BC-9F84-E619FEE864EAQ59132164-DF603DCD-ABE8-4A06-977C-C411AF756A54
P2860
Progressive augmentation and ventilatory long-term facilitation are enhanced in sleep apnoea patients and are mitigated by antioxidant administration.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Progressive augmentation and v ...... by antioxidant administration.
@en
Progressive augmentation and v ...... by antioxidant administration.
@nl
type
label
Progressive augmentation and v ...... by antioxidant administration.
@en
Progressive augmentation and v ...... by antioxidant administration.
@nl
prefLabel
Progressive augmentation and v ...... by antioxidant administration.
@en
Progressive augmentation and v ...... by antioxidant administration.
@nl
P2093
P2860
P1476
Progressive augmentation and v ...... by antioxidant administration.
@en
P2093
Dorothy S Lee
Jason H Mateika
M Safwan Badr
P2860
P304
P356
10.1113/JPHYSIOL.2009.178053
P407
P577
2009-10-05T00:00:00Z